Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Caredx Inc (NASDAQ: CDNA) was $24.07 for the day, down -3.41% from the previous closing price of $24.92. In other words, the price has decreased by -$3.41 from its previous closing price. On the day, 0.64 million shares were traded. CDNA stock price reached its highest trading level at $25.38 during the session, while it also had its lowest trading level at $24.04.
Ratios:
Our analysis of CDNA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1058.17. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Underweight rating and assigned the stock a target price of $28.
On August 19, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 04 ’24 when Novack Jeffrey Adam sold 1,917 shares for $26.00 per share. The transaction valued at 49,842 led to the insider holds 110,237 shares of the business.
Jeffrey Adam Novack bought 1,917 shares of CDNA for $47,848 on Dec 04 ’24. On Nov 26 ’24, another insider, Maag Peter, who serves as the Director of the company, sold 5,000 shares for $25.00 each. As a result, the insider received 125,000 and left with 330,024 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1336556544 and an Enterprise Value of 1080079232. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.13 while its Price-to-Book (P/B) ratio in mrq is 4.68. Its current Enterprise Value per Revenue stands at 3.453 whereas that against EBITDA is -24.406.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -3.87%, while the 200-Day Moving Average is calculated to be 25.06%.
Shares Statistics:
CDNA traded an average of 827.22K shares per day over the past three months and 696030 shares per day over the past ten days. A total of 53.11M shares are outstanding, with a floating share count of 50.16M. Insiders hold about 6.47% of the company’s shares, while institutions hold 97.26% stake in the company. Shares short for CDNA as of 1732838400 were 3337432 with a Short Ratio of 3.71, compared to 1730332800 on 3448286. Therefore, it implies a Short% of Shares Outstanding of 3337432 and a Short% of Float of 8.2100004.
